Suzanne K. Voburg, PhD

Associate Director
Uprise Health/Inflexxion
Irvine, California

Suzanne Vosburg, PhD has been a researcher in the field of substance use for over 20 years. She has worked in both human behavioral pharmacology laboratories and postmarketing surveillance settings investigating the abuse liability of prescription opioids and stimulants.

Presentation(s):

• P-020 - (Poster #20) Clinical Outcomes Translated to Healthcare Costs: Comparison of Buprenorphine Pain Medications with Full-agonist Extended-Release Opioids

  Thursday, September 4, 2025
  4:00 PM - 5:30 PM PST

• P-019 - (Poster #19) Opioid Abuse Deterrent Formulations: Evaluation of Nonmedical Use of Other Prescription Opioid Substances and Routes of Administration in Adults Evaluated for Substance Use Treatment with the Addiction Severity Index-Multimedia Version (ASI-MV®)

  Thursday, September 4, 2025
  4:00 PM - 5:30 PM PST

• P-021 - (Poster #21) Route of Administration and Other Clinical Outcomes Among Exposures to Buprenorphine Pain Medications and Schedule II Opioids

  Thursday, September 4, 2025
  4:00 PM - 5:30 PM PST

• P-022 - (Poster #22) Urine Drug Test Results from Patients with Chronic Pain Receiving Partial Agonist Versus Full Agonist Opioid Therapy

  Thursday, September 4, 2025
  4:00 PM - 5:30 PM PST